Composition
- Active ingredients
- DORAVIRINE 100MG; LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210807.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Delstrigo
- Active substance
- doravirine
- Drug class
- Non-nucleoside reverse transcriptase inhibitors, Antivirals for treatment of HIV infections, combinations, Nucleoside and nucleotide reverse transcriptase inhibitors
- Group
- Antivirals
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- MSD Merck Co